Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers
Open Access
- 1 February 2019
- journal article
- research article
- Published by Springer Nature in npj Genomic Medicine
- Vol. 4 (1) , 1-11
Abstract
The integration of genomic and DNA methylation data has been demonstrated as a powerful strategy in understanding cancer mechanisms and identifying therapeutic targets. The TCGA consortium has mapped DNA methylation in thousands of cancer samples using Illumina Infinium Human Methylation 450 K BeadChip (Illumina 450 K array) that only covers about 1.5% of CpGs in the human genome. Therefore, increasing the coverage of the DNA methylome would significantly leverage the usage of the TCGA data. Here, we present a new model called EAGLING that can expand the Illumina 450 K array data 18 times to cover about 30% of the CpGs in the human genome. We applied it to analyze 13 cancers in TCGA. By integrating the expanded methylation, gene expression, and somatic mutation data, we identified the genes showing differential patterns in each of the 13 cancers. Many of the triple-evidenced genes identified in majority of the cancers are biomarkers or potential biomarkers. Pan-cancer analysis also revealed the pathways in which the triple-evidenced genes are enriched, which include well known ones as well as new ones, such as axonal guidance signaling pathway and pathways related to inflammatory processing or inflammation response. Triple-evidenced genes, particularly TNXB, RRM2, CELSR3, SLC16A3, FANCI, MMP9, MMP11, SIK1, and TRIM59 showed superior predictive power in both tumor diagnosis and prognosis. These results have demonstrated that the integrative analysis using the expanded methylation data is powerful in identifying critical genes/pathways that may serve as new therapeutic targets.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (61503061)
- Foundation for the National Institutes of Health (HG009626)
This publication has 61 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- Identification of markers of prostate cancer progression using candidate gene expressionBritish Journal of Cancer, 2011
- Novel roles for Slits and netrins: axon guidance cues as anticancer targets?Nature Reviews Cancer, 2011
- The NIH Roadmap Epigenomics Mapping ConsortiumNature Biotechnology, 2010
- Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modificationsNature Biotechnology, 2010
- Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferationProstate Cancer and Prostatic Diseases, 2009
- Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancerBritish Journal of Cancer, 2009
- Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cellsBritish Journal of Cancer, 2007
- Inflammation and cancerNature, 2002